Caruso James Joseph 4

What Happened James Caruso, a director of Catheter Precision, received a grant of 40,000 derivative shares/options on March 26, 2026. The award was recorded at $0.00 per share (no cash paid at grant), so the immediate reported value is $0. This is an award/grant (not an open-market purchase or sale).

Key Details

• Transaction date: 2026-03-26; Filing date (Form 4): 2026-03-30 (timely per reporting rules).
• Instrument: Derivative grant (code A — award/grant/other acquisition) at $0.00.
• Quantity: 40,000 shares/options granted.
• Vesting: Footnote states the options vest 100% on the 180-day anniversary of the grant date.
• Shares owned after the transaction: Not specified in the provided filing excerpt.
• No indication of a 10b5-1 plan, tax withholding, or cashless exercise in the reported entry.

Context This filing documents a derivative award rather than an immediate purchase or sale. Because the award vests 100% after 180 days, the insider must remain in the position (and satisfy any plan terms) until that date to convert the grant into exercisable/owned shares. Awards at $0 cost often reflect options or restricted stock units granted as compensation; they do not represent an immediate cash transaction.